|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,390.00 INR | +0.47% |
|
+1.88% | -17.03% |
| 03/06 | Mankind Pharma Incorporates Not-for-Profit Subsidiary | MT |
| 02/06 | Maneane Pharma Limited Announces Intimation of Incorporation of A Wholly Owned Subsidiary Company | CI |
Evolution of the Average Target: Mankind Pharma Limited
Evolution of the Target Price: Mankind Pharma Limited
Changes in Analyst Recommendations: Mankind Pharma Limited
6260b7ea3612cfb6ec.8QBvSz5RQ-ykmD_7w3C-Qt79Ab3SdYxVtLsfOU422h8.3DMpA2hgFICX9FXPiASPcJuMWNCFJMcF7tlpSh5P4ivFT1k7WSAOhs7KBw~863548451201ff46f5fb569116424d18
More recommendations
| Consensus (Composite) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Ecart obj. / dr | ||
|---|---|---|---|---|---|---|
| +14.03% | ||||||
| +17.73% | ||||||
| +8.97% | ||||||
| +31.38% | ||||||
| +9.07% | ||||||
| +12.13% | ||||||
| - | +0.18% | |||||
| +21.25% | ||||||
| +26.73% | ||||||
| +7.84% | ||||||
| Average | +14.93% | |||||
| Weighted average by Cap. | +15.68% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
2,378.80INR
Average target price
2,712.47INR
Spread / Average Target
+14.03%
High Price Target
3,300.00INR
Spread / Highest target
+38.73%
Low Price Target
2,150.00INR
Spread / Lowest Target
-9.62%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Jefferies & Co. |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MANKIND Stock
- Consensus Mankind Pharma Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition